| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.056 | 0.3 |